International Journal of Molecular Sciences (Jan 2022)

Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions

  • Melissa Jones,
  • Corina Mihaela Ionescu,
  • Daniel Walker,
  • Susbin Raj Wagle,
  • Bozica Kovacevic,
  • Jacqueline Chester,
  • Thomas Foster,
  • Edan Johnston,
  • Jafri Kuthubutheen,
  • Daniel Brown,
  • Marcus D. Atlas,
  • Momir Mikov,
  • Armin Mooranian,
  • Hani Al-Salami

DOI
https://doi.org/10.3390/ijms23020836
Journal volume & issue
Vol. 23, no. 2
p. 836

Abstract

Read online

Biguanides, particularly the widely prescribed drug metformin, have been marketed for many decades and have well-established absorption profiles. They are commonly administered via the oral route and, despite variation in oral uptake, remain commonly prescribed for diabetes mellitus, typically type 2. Studies over the last decade have focused on the design and development of advanced oral delivery dosage forms using bio nano technologies and novel drug carrier systems. Such studies have demonstrated significantly enhanced delivery and safety of biguanides using nanocapsules. Enhanced delivery and safety have widened the potential applications of biguanides not only in diabetes but also in other disorders. Hence, this review aimed to explore biguanides’ pharmacokinetics, pharmacodynamics, and pharmaceutical applications in diabetes, as well as in other disorders.

Keywords